Source:http://linkedlifedata.com/resource/pubmed/id/20410488
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-5-20
|
pubmed:abstractText |
Although most cells are thought to respond to IFNs, there is limited information regarding specific cells that respond in vivo. Viperin is an IFN-induced antiviral protein and, therefore, is an excellent marker for IFN-responsive cells. In this study, we analyzed viperin expression in vivo during acute lymphocytic choriomeningitis virus Armstrong infection, which induces high levels of type I IFNs, and in persistently infected lymphocytic choriomeningitis virus carrier mice, which contain low levels of type I IFNs. Viperin was induced in lymphoid cells and dendritic cells (DCs) during acute infection and highly induced in neutrophils and macrophages. The expression kinetics in neutrophils, macrophages, and T and B cells paralleled IFN-alpha levels, but DCs expressed viperin with delayed kinetics. In carrier mice, viperin was expressed in neutrophils and macrophages but not in T and B cells or DCs. For acutely infected and carrier mice, viperin expression was IFN dependent, because treating type I IFNR knockout mice with IFN-gamma-neutralizing Abs inhibited viperin expression. Viperin localized to the endoplasmic reticulum and lipid droplet-like vesicles in neutrophils. These findings delineate the kinetics and cells responding to IFNs in vivo and suggest that the profile of IFN-responsive cells changes in chronic infections. Furthermore, these data suggest that viperin may contribute to the antimicrobial activity of neutrophils.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1550-6606
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
184
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5723-31
|
pubmed:meshHeading |
pubmed-meshheading:20410488-Acute Disease,
pubmed-meshheading:20410488-Animals,
pubmed-meshheading:20410488-Chronic Disease,
pubmed-meshheading:20410488-Interferon Type I,
pubmed-meshheading:20410488-Lymphocytic Choriomeningitis,
pubmed-meshheading:20410488-Lymphocytic choriomeningitis virus,
pubmed-meshheading:20410488-Lymphoid Tissue,
pubmed-meshheading:20410488-Macrophages,
pubmed-meshheading:20410488-Mice,
pubmed-meshheading:20410488-Mice, Inbred C57BL,
pubmed-meshheading:20410488-Neutrophils,
pubmed-meshheading:20410488-Phagocytosis,
pubmed-meshheading:20410488-Proteins,
pubmed-meshheading:20410488-Receptor, Interferon alpha-beta
|
pubmed:year |
2010
|
pubmed:articleTitle |
Viperin is highly induced in neutrophils and macrophages during acute and chronic lymphocytic choriomeningitis virus infection.
|
pubmed:affiliation |
Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|